Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lain

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Improving cancer therapy by non-genotoxic activation of p53S Lain, D Lane
British Journal of Cancer|November 16, 2013
p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapyB Rao, S Lain, A M Thompson
British Journal of Cancer|January 26, 2005
P53 abnormalities and outcomes in colorectal cancer: a systematic reviewA J Munro, S Lain, D P Lane
Journal of the American Medical Association|March 19, 2010
Actinomycosis of the face and neckJ H LAMB, E S LAIN, P E JONES
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|August 14, 2008
p53 as a therapeutic targetO D Staples, R J C Steele, S Lain
Journal of Investigational Allergology & Clinical Immunology|May 2, 2008
Fatal intraoperative anaphylaxis after aprotinin administrationA Prieto García, A Villanueva, S Lain, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2000
Activation of p53 in cervical carcinoma cells by small moleculesS Hietanen, S Lain, E Krausz, et al.
Current Biology : CB|January 1, 1997
Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1K L Ball, S Lain, R Fâhraeus, et al.
Molecular and Cellular Biology|October 25, 2000
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradationM S Rodriguez, J M Desterro, S Lain, et al.
Anaesthesia and Intensive Care|June 21, 2008
The accuracy of reporting of general anaesthesia for childbirth: a validation studyC L Roberts, J B Ford, S Lain, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Improving cancer therapy by non-genotoxic activation of p53S Lain, D Lane
British Journal of Cancer|November 16, 2013
p53-Based cyclotherapy: exploiting the 'guardian of the genome' to protect normal cells from cytotoxic therapyB Rao, S Lain, A M Thompson
British Journal of Cancer|January 26, 2005
P53 abnormalities and outcomes in colorectal cancer: a systematic reviewA J Munro, S Lain, D P Lane
Journal of the American Medical Association|March 19, 2010
Actinomycosis of the face and neckJ H LAMB, E S LAIN, P E JONES
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|August 14, 2008
p53 as a therapeutic targetO D Staples, R J C Steele, S Lain
Journal of Investigational Allergology & Clinical Immunology|May 2, 2008
Fatal intraoperative anaphylaxis after aprotinin administrationA Prieto García, A Villanueva, S Lain, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2000
Activation of p53 in cervical carcinoma cells by small moleculesS Hietanen, S Lain, E Krausz, et al.
Current Biology : CB|January 1, 1997
Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1K L Ball, S Lain, R Fâhraeus, et al.
Molecular and Cellular Biology|October 25, 2000
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradationM S Rodriguez, J M Desterro, S Lain, et al.
Anaesthesia and Intensive Care|June 21, 2008
The accuracy of reporting of general anaesthesia for childbirth: a validation studyC L Roberts, J B Ford, S Lain, et al.
Pageof 2